secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omega Therapeutics, Inc. (—)
CIK:        0001850838
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001193125-25-014403
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two Omega directors resign; Jeffrey Varsalone appointed to board
----------------------------------------------------------------

- Ravi Mehrotra and Robert Rosiello resigned from the board effective January 22, 2025.
- Board appointed Jeffrey Varsalone as Class I director effective January 24, 2025; monthly cash fee of $30,000.
- Richard Kender moved from Class III to Class II director to rebalance board classes.
- Board now consists of two directors per class (I, II, III).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525014403/0001193125-25-014403-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525014403/d893135d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-014403

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer